{"pmid":32279224,"title":"COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.","text":["COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.","Endocrine","Puig-Domingo, M","Marazuela, M","Giustina, A","32279224"],"journal":"Endocrine","authors":["Puig-Domingo, M","Marazuela, M","Giustina, A"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32279224","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s12020-020-02294-5","keywords":["Covid-19","Diabetes mellitus","Hypoadrenalism","Malnourishment","Obesity"],"source":"PubMed","topics":["Diagnosis","Prevention"],"weight":1,"_version_":1663890921999040512,"score":7.9164424,"similar":[{"pmid":32227671,"title":"COVID-19 Related School Closings and Risk of Weight Gain Among Children.","text":["COVID-19 Related School Closings and Risk of Weight Gain Among Children.","The COVID-19 pandemic is causing substantial morbidity and mortality, straining health care systems, shutting down economies, and closing school districts. While it is a priority to mitigate its immediate impact, we want to call attention to the pandemic's longer-term effect on children's health: COVID-19, via these school closures, may exacerbate the epidemic of childhood obesity and increase disparities in obesity risk. In many areas of the U.S., the COVID-19 pandemic has closed schools and some of these school systems are not expected to re-open this school year. The experiences in Hong Kong, Taiwan and Singapore suggest that social distancing orders, if lifted after short periods, will have to be periodically re-instated to control COVID-19 flare ups. In short, we anticipate that the COVID-19 pandemic will likely double out-of-school time this year for many children in the U.S. and will exacerbate the risk factors for weight gain associated with summer recess.","Obesity (Silver Spring)","Rundle, Andrew G","Park, Yoosun","Herbstman, Julie B","Kinsey, Eliza W","Wang, Y Claire","32227671"],"abstract":["The COVID-19 pandemic is causing substantial morbidity and mortality, straining health care systems, shutting down economies, and closing school districts. While it is a priority to mitigate its immediate impact, we want to call attention to the pandemic's longer-term effect on children's health: COVID-19, via these school closures, may exacerbate the epidemic of childhood obesity and increase disparities in obesity risk. In many areas of the U.S., the COVID-19 pandemic has closed schools and some of these school systems are not expected to re-open this school year. The experiences in Hong Kong, Taiwan and Singapore suggest that social distancing orders, if lifted after short periods, will have to be periodically re-instated to control COVID-19 flare ups. In short, we anticipate that the COVID-19 pandemic will likely double out-of-school time this year for many children in the U.S. and will exacerbate the risk factors for weight gain associated with summer recess."],"journal":"Obesity (Silver Spring)","authors":["Rundle, Andrew G","Park, Yoosun","Herbstman, Julie B","Kinsey, Eliza W","Wang, Y Claire"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227671","week":"202014|Mar 30 - Apr 05","doi":"10.1002/oby.22813","keywords":["COVID-19","Childen","Obesity","Summer Recess"],"source":"PubMed","locations":["Singapore","USA","China"],"countries":["China","Singapore","United States"],"countries_codes":["CHN|China","SGP|Singapore","USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1663352135297794050,"score":63.946976},{"pmid":32259611,"title":"COVID-19 Infection in italian people with diabetes: lessons learned for our future (an experience to be used).","text":["COVID-19 Infection in italian people with diabetes: lessons learned for our future (an experience to be used).","Diabetes Res Clin Pract","Gentile, Sandro","Strollo, Felice","Ceriello, Antonio","32259611"],"journal":"Diabetes Res Clin Pract","authors":["Gentile, Sandro","Strollo, Felice","Ceriello, Antonio"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259611","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.diabres.2020.108137","keywords":["COVID-19","Diabetes mellitus","Italy","chronically ill patients","comorbidities"],"source":"PubMed","locations":["italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1663450393532694528,"score":58.997234},{"pmid":32242340,"title":"Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: a statement of the Society of European Robotic Gynaecological Surgery (SERGS).","text":["Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: a statement of the Society of European Robotic Gynaecological Surgery (SERGS).","All surgery performed in an epicenter of the coronavirus disease 2019 (COVID-19) pandemic, irrespective of the known or suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) status of the patient, should be regarded as high risk and protection of the surgical team at the bedside should be at the highest level. Robot assisted surgery (RAS) may help to reduce hospital stay for patients that urgently need complex-oncological-surgery, thus making room for COVID-19 patients. In comparison to open or conventional laparoscopic surgery, RAS potentially reduces not only contamination with body fluids and surgical gasses of the surgical area but also the number of directly exposed medical staff. A prerequisite is that general surgical precautions under COVID-19 circumstances must be taken, with the addition of prevention of gas leakage: * Use highest protection level III for bedside assistant, but level II for console surgeon. * Reduce the number of staff at the operation room. * Ensure safe and effective gas evacuation. * Reduce the intra-abdominal pressure to 8 mmHg or below. * Minimize electrocautery power and avoid use of ultrasonic sealing devices. * Surgeons should avoid contact outside theater (both in and out of the hospital).","J Gynecol Oncol","Kimmig, Rainer","Verheijen, Rene H M","Rudnicki, Martin","32242340"],"abstract":["All surgery performed in an epicenter of the coronavirus disease 2019 (COVID-19) pandemic, irrespective of the known or suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) status of the patient, should be regarded as high risk and protection of the surgical team at the bedside should be at the highest level. Robot assisted surgery (RAS) may help to reduce hospital stay for patients that urgently need complex-oncological-surgery, thus making room for COVID-19 patients. In comparison to open or conventional laparoscopic surgery, RAS potentially reduces not only contamination with body fluids and surgical gasses of the surgical area but also the number of directly exposed medical staff. A prerequisite is that general surgical precautions under COVID-19 circumstances must be taken, with the addition of prevention of gas leakage: * Use highest protection level III for bedside assistant, but level II for console surgeon. * Reduce the number of staff at the operation room. * Ensure safe and effective gas evacuation. * Reduce the intra-abdominal pressure to 8 mmHg or below. * Minimize electrocautery power and avoid use of ultrasonic sealing devices. * Surgeons should avoid contact outside theater (both in and out of the hospital)."],"journal":"J Gynecol Oncol","authors":["Kimmig, Rainer","Verheijen, Rene H M","Rudnicki, Martin"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32242340","week":"202014|Mar 30 - Apr 05","doi":"10.3802/jgo.2020.31.e59","keywords":["COVID-19","Personal Protective Equipment","Robot Assisted Surgery"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352135749730304,"score":54.91409},{"pmid":32272473,"title":"Pediatric Endocrinology in the Time of the COVID-19 Pandemic.","text":["Pediatric Endocrinology in the Time of the COVID-19 Pandemic.","Horm Res Paediatr","Cianfarani, Stefano","32272473"],"journal":"Horm Res Paediatr","authors":["Cianfarani, Stefano"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32272473","week":"202015|Apr 06 - Apr 12","doi":"10.1159/000507703","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1663620083014959105,"score":53.62204},{"pmid":32220179,"title":"[The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].","text":["[The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].","Based on the higher mortality and the higher proportion of critically ill adults in coronavirus disease 2019 (COVID-19) patients with diabetes, good inpatient glycemic control is particularly important in the comprehensive treatment of COVID-19. Individualized blood glucose target goals and treatment strategies should be made according to specific circumstances of COVID-19 inpatients with diabetes. For mild patients, a strict glycemic control target (fasting plasma glucose (FPG) 4.4-6.1 mmol/L, 2-hour postprandial plasma glucose (2 h PG) 6.1-7.8 mmol/L) are recommended; a target for the glycemic control of common type patients (FPG 6.1-7.8 mmol/L, 2 h PG 7.8-10.0 mmol/L) and subcutaneous insulin deliver therapy are recommended; a target nonfasting blood glucose range of 10.0 mmol or less per liter for severe-type COVID-19 patients, a relatively Less stringent blood glucose control target (FPG 7.8-10.0 mmol/L, 2 h PG 7.8-13.9 mmol/L) for critically ill patients and intravenous insulin infusion therapy are recommended. Due to the rapid changes in the condition of some patients, the risk of diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar status (HHS) maybe occur during the treatment. Blood glucose monitoring, dynamic evaluation and timely adjustment of strategies should be strengthened to ensure patient safety and promote early recovery of patients.","Sichuan Da Xue Xue Bao Yi Xue Ban","Ma, Wan-Xia","Ran, Xing-Wu","32220179"],"abstract":["Based on the higher mortality and the higher proportion of critically ill adults in coronavirus disease 2019 (COVID-19) patients with diabetes, good inpatient glycemic control is particularly important in the comprehensive treatment of COVID-19. Individualized blood glucose target goals and treatment strategies should be made according to specific circumstances of COVID-19 inpatients with diabetes. For mild patients, a strict glycemic control target (fasting plasma glucose (FPG) 4.4-6.1 mmol/L, 2-hour postprandial plasma glucose (2 h PG) 6.1-7.8 mmol/L) are recommended; a target for the glycemic control of common type patients (FPG 6.1-7.8 mmol/L, 2 h PG 7.8-10.0 mmol/L) and subcutaneous insulin deliver therapy are recommended; a target nonfasting blood glucose range of 10.0 mmol or less per liter for severe-type COVID-19 patients, a relatively Less stringent blood glucose control target (FPG 7.8-10.0 mmol/L, 2 h PG 7.8-13.9 mmol/L) for critically ill patients and intravenous insulin infusion therapy are recommended. Due to the rapid changes in the condition of some patients, the risk of diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar status (HHS) maybe occur during the treatment. Blood glucose monitoring, dynamic evaluation and timely adjustment of strategies should be strengthened to ensure patient safety and promote early recovery of patients."],"journal":"Sichuan Da Xue Xue Bao Yi Xue Ban","authors":["Ma, Wan-Xia","Ran, Xing-Wu"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32220179","week":"202013|Mar 23 - Mar 29","doi":"10.12182/20200360606","keywords":["Blood glucose level","Blood glucose monitoring","Coronavirus disease 2019, COVID-19","Diabetes mellitus","Inpatient glycemic control","Insulin","Therapy"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Blood Glucose"],"_version_":1663352135093321728,"score":53.45537}]}